Mekong Capital announced that the Vietnam Azalea Fund Limited (“the Fund”) has invested more than US$3 million in Traphaco Joint Stock Co (“Traphaco”). Vu Thi Thuan, the Chairwoman and CEO of Traphaco said: “Traphaco was previously a state owned pharmaceutical company, which was equitised to operate as a joint stock company in 1999. After equitisation, the company’s revenue has continuously been increasing at high rate. Traphaco is now one of the leading companies in Vietnamese traditional medicine sector. Traphaco has selected Vietnam Azalea Fund Limited as a strategic investor for the added values that the Fund will bring to our company. We found a mutual understanding and trust while working with the Fund and its management company, Mekong Capital. An investment by the Fund not only reflects the success of Traphaco but also fuels the company to strengthen its market leadership while pursuing long-term growth strategy.”
Duong Do Quyen, Portfolio manager of Vietnam Azalea Fund Limited at Mekong Capital said: “We are very excited about the Fund’s investment in Traphaco. There are many success stories about investing in traditional medicine companies. We highly appreciate Traphaco’s strategic vision and its effective business result in the recent years. The company has established itself as the leading company in supplying traditional medicine and well positioned to capture potential opportunities in Vietnam and regional markets. We plan to work closely with the company to further strengthen its capabilities in various areas such as financial and accounting management and corporate governance.”
About Traphaco joint stock company
Traphaco is a pharmaceutical company with rich and extensive experience in the industry. It is one of the leading companies in development and promotion of Vietnamese traditional medicines. Traphaco produces and sells more than 230 products of various types such as: central nervous system, digestive, cardiovascular, analgesics, respiratory and ontological system, eye care, etc. and they are distributed throughout the country. At present, the company operates two GMP-complied factories in Hanoi and Hung Yen. Traphaco’s factories use high-tech pharmaceutical equipment system imported mostly from Germany and Korea. These facilities allow the Co to meet the high demand of high quality and reliable products. With the slogan “Traditional character with Modern technology”, Traphaco brand has become more and more popular to the consumers. Traphaco has established its firm position in pharmaceutical market and it is really a brand of Vietnam traditional medicines.
For more information about Traphaco, please visit the website www.traphaco.com.vn
About Vietnam Azalea Fund Limited
Vietnam Azalea Fund Limited is a US$100 million fund (at the first phrase) with prestigious financial institutional and private investors from US and Europe. The Fund focuses on investment in pre-listed equitised (privatised) companies in Vietnam. After receiving the Fund’s investment, the investee companies most likely will be listed on a the stock exchange in one or two-years. Especially, the Fund aims to make investment in the company with strong commitment to build excellent management team. The Fund’s manager, Mekong Capital, works closely with investee companies to help them prepare for successful listings on a stock exchange. The Investment manager of Vietnam Azalea Fund is Mekong Capital Ltd For more information on Mekong Capital, please visit the website www.mekongcapital.com. For more information, please contact:
Phan Bich Ha PR manager Mekong Capital Ltd E-mail: email@example.com